|
Hormone/Cytokine Concentrations. |
|||
| Variable |
AA (n = 15) |
PLA (n = 16) |
Significance |
|
|
|||
| PGF2α (pg·ml-1) |
|||
| Day 0 |
164.6 ± 104.4 |
183.6 ± 96.0 |
Group: 0.89 |
| Day 25 |
221.5 ± 153.2 |
281.5 ± 248.2 |
Time: 0.06 |
| Day 50 |
209.7 ± 226.3 |
150.0 ± 104.5 |
G × T: 0.14 |
| PGE2 (pg·ml-1) |
|||
| Day 0 |
224.3 ± 145.7 |
293.6 ± 256.7 |
Group: 0.97 |
| Day 25 |
288.5 ± 191.2 |
314.8 ± 236.1 |
Time: 0.65 |
| Day 50 |
322.8 ± 281.2 |
219.9 ± 163.6 |
G × T: 0.06 |
| tTEST (ng·ml-1) |
|||
| Day 0 |
21.4 ± 24.8 |
14.0 ± 12.1 |
Group: 0.25 |
| Day 25 |
18.7 ± 22.4 |
12.2 ± 7.1 |
Time: 0.24 |
| Day 50 |
18.7 ± 18.3 |
12.2 ± 7.7 |
G × T: 0.83 |
| fTEST (pg·ml-1) |
|||
| Day 0 |
25.3 ± 14.7 |
24.9 ± 19.6 |
Group: 0.82 |
| Day 25 |
23.1 ± 12.1 |
20.0 ± 12.1 |
Time: 0.03 |
| Day 50 |
22.3 ± 13.6 |
22.3 ± 15.0 |
G × T: 0.87 |
| CORT (μg·dl-1) |
|||
| Day 0 |
34.0 ± 24.1 |
26.2 ± 10.6 |
Group: 0.44 |
| Day 25 |
28.2 ± 20.0 |
23.1 ± 7.8 |
Time: 0.06 |
| Day 50 |
36.8 ± 22.9 |
34.2 ± 35.8 |
G × T: 0.57 |
| IL-6 (pg·ml-1) |
|||
| Day 0 |
137.2 ± 69.6 |
120.1 ± 92.1 |
Group: 0.63 |
| Day 25 |
138.0 ± 83.1b |
172.6 ± 90.5a |
Time: 0.001 |
| Day 50 |
108.4 ± 48.6a |
127.0 ± 56.8 |
G × T: 0.03 |
|
Values are expressed as means ± SD. AA: Arachidonic acid, PLA: placebo, PGF2α: prostaglandin F2α, PGE2: prostaglandin E2, tTEST: total testosterone, fTEST: free testosterone, CORT: cortisol, IL-6: interleukin-6. aSignificant within-group difference from baseline values, p < 0.05. bSignificant group × time (G × T) interaction, p < 0.05. | |||
Roberts et al. Journal of the International Society of Sports Nutrition 2007 4:21 doi:10.1186/1550-2783-4-21 |
|||